KM SMED ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  2.7% 2.7% 2.7% 2.7% 2.7%  
Bankruptcy risk  2.5% 7.3% 4.8% 2.8% 2.2%  
Credit score (0-100)  64 33 43 59 65  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,222 947 1,014 1,535 1,154  
EBITDA  164 29.4 45.3 499 146  
EBIT  126 2.1 10.1 457 89.2  
Pre-tax profit (PTP)  160.2 38.4 34.9 470.2 106.6  
Net earnings  114.5 29.7 27.2 366.2 83.0  
Pre-tax profit without non-rec. items  160 38.4 34.9 470 107  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  69.8 113 77.3 221 164  
Shareholders equity total  757 287 314 680 763  
Interest-bearing liabilities  280 236 246 69.7 74.8  
Balance sheet total (assets)  1,399 1,168 1,128 1,773 1,554  

Net Debt  280 231 232 -10.2 -215  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,222 947 1,014 1,535 1,154  
Gross profit growth  52.5% -22.5% 7.1% 51.4% -24.8%  
Employees  2 2 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,399 1,168 1,128 1,773 1,554  
Balance sheet change%  -27.7% -16.5% -3.5% 57.2% -12.3%  
Added value  164.4 29.4 45.3 491.8 145.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -50 15 -70 100 -113  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  10.3% 0.2% 1.0% 29.7% 7.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  10.9% 3.6% 3.9% 33.5% 7.2%  
ROI %  14.0% 6.0% 8.2% 73.9% 15.1%  
ROE %  16.4% 5.7% 9.0% 73.6% 11.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  54.1% 24.6% 27.9% 38.4% 49.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  170.2% 786.5% 512.1% -2.0% -147.8%  
Gearing %  36.9% 82.3% 78.2% 10.2% 9.8%  
Net interest  0 0 0 0 0  
Financing costs %  3.6% 3.2% 3.9% 9.6% 18.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.0 1.2 1.3 1.4 1.7  
Current Ratio  2.1 1.2 1.3 1.4 1.8  
Cash and cash equivalent  0.0 5.0 13.6 79.9 290.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  688.8 178.1 237.0 464.3 602.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  82 15 23 246 73  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  82 15 23 250 73  
EBIT / employee  63 1 5 228 45  
Net earnings / employee  57 15 14 183 41